Cargando…
Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer’s disease
BACKGROUND: Alzheimer’s disease is a progressive neurodegenerative disorder that is hypothesized to involve epigenetic dysfunction. Previous studies of DNA modifications in Alzheimer’s disease have been unable to distinguish between DNA methylation and DNA hydroxymethylation. DNA hydroxymethylation...
Autores principales: | Smith, Adam R., Smith, Rebecca G., Pishva, Ehsan, Hannon, Eilis, Roubroeks, Janou A. Y., Burrage, Joe, Troakes, Claire, Al-Sarraj, Safa, Sloan, Carolyn, Mill, Jonathan, van den Hove, Daniel L., Lunnon, Katie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429761/ https://www.ncbi.nlm.nih.gov/pubmed/30898171 http://dx.doi.org/10.1186/s13148-019-0636-y |
Ejemplares similares
-
Variation in 5-hydroxymethylcytosine across human cortex and cerebellum
por: Lunnon, Katie, et al.
Publicado: (2016) -
Erratum to: Variation in 5-hydroxymethylcytosine across human cortex and cerebellum
por: Lunnon, Katie, et al.
Publicado: (2016) -
DNA methylation signatures of Alzheimer’s disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types
por: Shireby, Gemma, et al.
Publicado: (2022) -
Cross-tissue methylomic profiling strongly implicates a role for cortex-specific deregulation of ANK1 in Alzheimer’s disease neuropathology
por: Lunnon, Katie, et al.
Publicado: (2014) -
An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene
por: Roubroeks, Janou A.Y., et al.
Publicado: (2020)